Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors

Kimberly Noonan, William Matsui, Paolo Serafini, Rebecca Carbley, Gladys Tan, Jahan Khalili, Mark Bonyhadi, Hyam Levitsky, Katie Whartenby, Ivan Borrello

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

A major limitation of adoptive immunotherapy is the availability of T cells specific for both terminally differentiated tumor cells and their clonogenic precursors. We show here that marrow-infiltrating lymphocytes (MILs) recognize myeloma cells after activation with anti-CD3/CD28 beads with higher frequency than activated peripheral blood lymphocytes from the same patients. Furthermore, activated MILs target both the terminally differentiated CD138+ plasma cells and the myeloma precursor as shown by profound inhibition in a tumor clonogenic assay. The presence of antigen in the marrow microenvironment seems to be important for the maintenance of tumor specificity. Taken together, these results highlight the intrinsic tumor specificity of MILs and describe a novel approach for the generation of tumor-specific T-cell populations suitable for adoptive immunotherapy of multiple myeloma.

Original languageEnglish
Pages (from-to)2026-2034
Number of pages9
JournalCancer Research
Volume65
Issue number5
DOIs
StatePublished - Mar 1 2005
Externally publishedYes

Fingerprint

Plasma Cells
Bone Marrow
Lymphocytes
Adoptive Immunotherapy
Neoplasms
Multiple Myeloma
T-Lymphocytes
Maintenance
Antigens
Population

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors. / Noonan, Kimberly; Matsui, William; Serafini, Paolo; Carbley, Rebecca; Tan, Gladys; Khalili, Jahan; Bonyhadi, Mark; Levitsky, Hyam; Whartenby, Katie; Borrello, Ivan.

In: Cancer Research, Vol. 65, No. 5, 01.03.2005, p. 2026-2034.

Research output: Contribution to journalArticle

Noonan, K, Matsui, W, Serafini, P, Carbley, R, Tan, G, Khalili, J, Bonyhadi, M, Levitsky, H, Whartenby, K & Borrello, I 2005, 'Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors', Cancer Research, vol. 65, no. 5, pp. 2026-2034. https://doi.org/10.1158/0008-5472.CAN-04-3337
Noonan, Kimberly ; Matsui, William ; Serafini, Paolo ; Carbley, Rebecca ; Tan, Gladys ; Khalili, Jahan ; Bonyhadi, Mark ; Levitsky, Hyam ; Whartenby, Katie ; Borrello, Ivan. / Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors. In: Cancer Research. 2005 ; Vol. 65, No. 5. pp. 2026-2034.
@article{6ce114e9b9944902a19a00ab3032ed8c,
title = "Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors",
abstract = "A major limitation of adoptive immunotherapy is the availability of T cells specific for both terminally differentiated tumor cells and their clonogenic precursors. We show here that marrow-infiltrating lymphocytes (MILs) recognize myeloma cells after activation with anti-CD3/CD28 beads with higher frequency than activated peripheral blood lymphocytes from the same patients. Furthermore, activated MILs target both the terminally differentiated CD138+ plasma cells and the myeloma precursor as shown by profound inhibition in a tumor clonogenic assay. The presence of antigen in the marrow microenvironment seems to be important for the maintenance of tumor specificity. Taken together, these results highlight the intrinsic tumor specificity of MILs and describe a novel approach for the generation of tumor-specific T-cell populations suitable for adoptive immunotherapy of multiple myeloma.",
author = "Kimberly Noonan and William Matsui and Paolo Serafini and Rebecca Carbley and Gladys Tan and Jahan Khalili and Mark Bonyhadi and Hyam Levitsky and Katie Whartenby and Ivan Borrello",
year = "2005",
month = "3",
day = "1",
doi = "10.1158/0008-5472.CAN-04-3337",
language = "English",
volume = "65",
pages = "2026--2034",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors

AU - Noonan, Kimberly

AU - Matsui, William

AU - Serafini, Paolo

AU - Carbley, Rebecca

AU - Tan, Gladys

AU - Khalili, Jahan

AU - Bonyhadi, Mark

AU - Levitsky, Hyam

AU - Whartenby, Katie

AU - Borrello, Ivan

PY - 2005/3/1

Y1 - 2005/3/1

N2 - A major limitation of adoptive immunotherapy is the availability of T cells specific for both terminally differentiated tumor cells and their clonogenic precursors. We show here that marrow-infiltrating lymphocytes (MILs) recognize myeloma cells after activation with anti-CD3/CD28 beads with higher frequency than activated peripheral blood lymphocytes from the same patients. Furthermore, activated MILs target both the terminally differentiated CD138+ plasma cells and the myeloma precursor as shown by profound inhibition in a tumor clonogenic assay. The presence of antigen in the marrow microenvironment seems to be important for the maintenance of tumor specificity. Taken together, these results highlight the intrinsic tumor specificity of MILs and describe a novel approach for the generation of tumor-specific T-cell populations suitable for adoptive immunotherapy of multiple myeloma.

AB - A major limitation of adoptive immunotherapy is the availability of T cells specific for both terminally differentiated tumor cells and their clonogenic precursors. We show here that marrow-infiltrating lymphocytes (MILs) recognize myeloma cells after activation with anti-CD3/CD28 beads with higher frequency than activated peripheral blood lymphocytes from the same patients. Furthermore, activated MILs target both the terminally differentiated CD138+ plasma cells and the myeloma precursor as shown by profound inhibition in a tumor clonogenic assay. The presence of antigen in the marrow microenvironment seems to be important for the maintenance of tumor specificity. Taken together, these results highlight the intrinsic tumor specificity of MILs and describe a novel approach for the generation of tumor-specific T-cell populations suitable for adoptive immunotherapy of multiple myeloma.

UR - http://www.scopus.com/inward/record.url?scp=20144389307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20144389307&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-04-3337

DO - 10.1158/0008-5472.CAN-04-3337

M3 - Article

VL - 65

SP - 2026

EP - 2034

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 5

ER -